Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of SYN118 (nitisinone) as adjunctive therapy in Parkinson's disease
2009-013670-41Phase 2Completed
- Sponsor
- Synosia Therapeutics
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing SYN118 (nitisinone) adjunctive arm with Placebo adjunctive arm (2 arms). Started Sep 2009; status: completed.
02
Drugs
nitisinone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-013670-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013670-41.